Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Engineered TGF-beta monomers and their use for inhibiting TGF-beta signaling

Engineered TGF-beta monomers and their use for inhibiting TGF-beta signaling

US Patent 12428460 · Granted Sep 30, 2025

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Anti-G-CSF antibodies and uses thereof2025
TGF-β-receptor ectodomain fusion molecules and uses thereof2025
Antibody variants with pH-dependent antigen binding for selective targeting of s2025
Antibodies selective for cells presenting EGFR at high density2024
Antibodies and antibody fragments against HNAV1.7 channel and their use in pain 2024
TGF-β-receptor ectodomain fusion molecules and uses thereof2024
Antibody glycoconjugates and methods of production and use2023
TGFbeta type II-type III receptor fusions2022
Serum albumin binding antibodies for tuneable half-life extension of biologics2022
Humanized anti-S100A9 antibody and uses thereof2022
Engineered TGF-β monomers and their use for inhibiting TGF-β signaling2021
Engineered TGF-β monomers and their use for inhibiting TGF-β signaling2021